Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer
出版年份 2013 全文链接
标题
Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer
作者
关键词
Overall Survival, Docetaxel, Androgen Deprivation Therapy, Abiraterone, Enzalutamide
出版物
DRUGS
Volume 73, Issue 15, Pages 1723-1732
出版商
Springer Nature
发表日期
2013-10-14
DOI
10.1007/s40265-013-0129-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 785 EFFICACY OUTCOMES BY BASELINE PROSTATE-SPECIFIC ANTIGEN (PSA): RESULTS FROM THE PHASE 3 AFFIRM TRIAL
- (2013) Fred Saad et al. JOURNAL OF UROLOGY
- 982 COMBINED TARGETING OF PI3K/AKT AND AR PATHWAY WITH AZD5363 AND ENZALUTAMIDE INDUCES ANTICANCER ACTIVITY IN PRECLINICAL MODELS OF PROSTATE CANCER
- (2013) Paul Toren et al. JOURNAL OF UROLOGY
- NF- B2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants
- (2013) N. Nadiminty et al. MOLECULAR CANCER THERAPEUTICS
- Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer
- (2013) Javier Guerrero et al. PROSTATE
- Overcoming mutation-based resistance to antiandrogens with rational drug design
- (2013) Minna D Balbas et al. eLife
- Recent advances in second-line treatment of castration-resistant prostate cancer
- (2013) Michael Ong et al. Current Opinion in Supportive and Palliative Care
- Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
- (2012) Che-Kai Tsao et al. BJU INTERNATIONAL
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Management of Metastatic Castration-Resistant Prostate Cancer
- (2012) Deborah Mukherji et al. DRUGS
- Optimal Management of Recurrent Prostate Cancer in Older Patients
- (2012) Elizabeth R. Kessler et al. DRUGS & AGING
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone Acetate
- (2011) Lily P.H. Yang DRUGS
- Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer
- (2011) Neeraj Agarwal et al. EUROPEAN UROLOGY
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Sipuleucel-T
- (2010) Greg L. Plosker DRUGS
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started